LONDON (Reuters) – Positive news on initial trials of the University of Oxford’s potential COVID-19 vaccine that has been licensed to AstraZeneca could be announced as soon as Thursday, ITV’s political editor Robert Peston said, citing a source.
The project has started Phase III of the human trials to assess how the vaccine works in a large number of people over the age of 18, but has yet to report Phase I trial results.
The developers of the vaccine earlier this month said they are encouraged by the immune response they have seen in trials so far. [nL8N2E84YY]
“I am hearing there will be positive news soon (perhaps tomorrow) on initial trials of the Oxford Covid-19 vaccine that is backed by AstraZeneca,” Peston said in a blog post on Wednesday.
(Reporting by William Schomberg, writing by Alistair Smout; editing by Michael Holden)
